
Merck's Dr Dave Maraldo explains that small-molecule platform agility and flexible conjugation capacity can help biologics manufacturing respond to research needs.
Eric Langer, Managing partner at BioPlan Associates, speaks with BioPharm International about biosimilar development trends.
Eric Langer, Managing Partner at BioPlan Associates, spoke with BioPharm International about biosimilar development trends.






